Plain-English translation of NCT07634978 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Thyroid Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new artificial intelligence chatbot designed to support thyroid cancer patients before and after surgery. The chatbot provides personalized, round-the-clock answers to questions about surgery preparation, recovery, medication management, diet, and follow-up care. Half of the patients will receive standard care from nursing staff, while the other half will also have access to the AI chatbot to see if it improves their experience and understanding.
Modern thyroid cancer surgery programs have shortened hospital stays, which means patients spend less time talking face-to-face with their healthcare team. This trial exists to explore whether a 24/7 chatbot can fill that gap by providing instant, personalized answers to patients' questions during the critical weeks before and after surgery.
You likely qualify if…
You likely don't qualify if…
If you join during the first phase, you will receive the usual health education from your nursing team. If you join during the second phase, you will receive that same care plus access to the AI chatbot on your phone or computer whenever you need it. Both groups will be asked to complete surveys about their experience on the morning you leave the hospital.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
China